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Newly Identified Enterovirus C Genotypes, Identified in the
Netherlands through Routine Sequencing of All Enteroviruses
Detected in Clinical Materials from 2008 to 2015
Coretta C. Van Leer-Buter, Randy Poelman, Renze Borger, Hubert G. M. Niesters
The University of Groningen, University Medical Center Groningen, Department of Medical Microbiology, Division of Clinical Virology, Groningen, the Netherlands
Enteroviruses (EVs) are a group of human and animal viruses that are capable of causing a variety of clinical syndromes. Differ-
ent genotypes classified into species can be distinguished on the basis of sequence divergence in the VP1 capsid-coding region.
Apparently new genotypes are discovered regularly, often as incidental findings in studies investigating respiratory syndromes
or as part of poliovirus surveillance. Recently, some EVs have become recognized as significant respiratory pathogens, and a
number of new genotypes belonging to species C have been identified. The circulation of these newly identified species C EVs,
such as EV-C104, EV-C105, EV-C109, and EV-C117, nevertheless appears to be limited. In this report, we show the results of rou-
tine genotyping of all enteroviruses detected in our tertiary care hospital between January 2008 and April 2015. We detected 365
EVs belonging to 40 genotypes. Interestingly, several newly identified species C EVs were detected during the study period. Se-
quencing of the 5= untranslated region (5= UTR) of these viruses shows divergence in this region, which is a target region in many
detection assays.
Enteroviruses (EVs) are common pathogens that are associatedwith various clinical syndromes involving different organ sys-
tems. Historically, EVs were classified according to clinical, sero-
logical, and culture characteristics, but currently, sequence diver-
gence in the VP1 capsid-coding region is used for allocation of
these viruses into different genotypes. Together with the closely
related rhinoviruses, EV species belong to the genus Enterovirus in
the family Picornaviridae (1). To date, 8 EV species are recognized,
A to H, of which species A to D are known to cause disease in
humans. Strains that have less than 75% nucleotide and 85%
amino acid similarity in the VP1 region are classified as different
genotypes (2, 3). Newly identified EV strains are regularly re-
ported (4). Infections caused by EVs include hand-foot-and-
mouth disease (HFMD), myocarditis, respiratory infections,
meningitis, and acute flaccid paralysis (AFP) (1). Although some
clinical conditions are classically associated with one or more EV
genotypes, such as AFP, which before mass vaccination used to be
most commonly caused by polioviruses, it is apparent that each
EV type is capable of causing a variety of clinical syndromes and
that a particular clinical syndrome may be caused by a variety of
EV types. Correspondingly, EV-A71, which causes HFMD, is also
capable of causing neurological infections (5). Additionally, neu-
rological infections as well as HFMD can be caused by a variety of
EV genotypes (6, 7). Most EV infections are nevertheless subclin-
ical, and their circulation in the population goes unnoticed. Inter-
national surveillance of EVs is limited but exists for poliovirus. In
addition, many countries have a surveillance system at the na-
tional level for cases of AFP and neurological infections caused by
EVs other than poliovirus (8, 9). Data about circulating EV geno-
types are thereby generated, but these data are not comprehensive.
EVs, beyond poliovirus, continue to be important pathogens. In-
deed, during the summer of 2014, an unprecedented outbreak of
EV-D68 occurred, affecting thousands of people in North Amer-
ica as well as in Europe (10, 11). This outbreak highlights first that
EV outbreaks are unlikely to remain confined to a single geo-
graphical area and second that EVs may be the cause of severe
respiratory illness.
Respiratory samples have also been the source fromwhich sev-
eral new members of the EV-C species have been first identified.
EV-C104 was first found in Switzerland in 2005 in respiratory
samples from patients with respiratory illnesses. Since then, EV-
C104 was found sporadically in Italy, Japan, and Gambia (12–15).
EV-C105 was first identified in the fecal sample of a Congolese
man with AFP; however, this virus was subsequently detected in
respiratory samples in Italy, Peru, Cyprus, New Zealand (16–19),
andmost recently in another case of AFP in theUnited States (20).
EV-C109 was first identified in respiratory samples in Nicaragua
(21). Since its first description, it has been detected in respiratory
samples in Italy and Hungary and in a fecal sample in Congo
(22–24). EV-C117 was first found in a Lithuanian child with
pneumonia (25). However, in total so far, about 25 reported cases
of EV-C104 have been described over a period of 10 years, and for
the other “new” EV-C species viruses, this number is even lower.
Sequence information is limited.
In the present study, we show the results of the routine se-
quencing strategy applied in our clinical virology laboratory for all
EVs detected between January 2008 and April 2015.
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Screening of clinical samples. Our laboratory is part of a tertiary care
university hospital. Clinical materials are received from patients who are
admitted as well as from patients who visit outpatient clinics. Because the
hospital is the country’s largest organ transplantation center, two-thirds
of its patients are immunocompromised.
All cerebral spinal fluid (CSF) samples frompatients with neurological
symptoms, respiratory samples from patients with respiratory symptoms,
and fecal samples of patients with diarrhea and gastrointestinal symptoms
referred to the clinical virology laboratory were screened for EVs. All
materials were screened with our routine screening multiplex reverse
transcriptase PCR (RT-PCR) assays, which include a minimum of 5 tar-
gets in CSF (herpes simplex viruses 1 and 2, varicella-zoster virus, entero-
virus, and parechovirus), 14 viral targets in respiratory samples (including
Influenza A and B, rhinovirus, coronaviruses, parainfluenza viruses, ade-
novirus, bocavirus, respiratory syncytial virus [RSV], and human meta-
pneumovirus [HMPV]), and 8 viral targets for fecal samples (adenovirus,
bocavirus, rotavirus, astrovirus, sapovirus, norovirus, enterovirus, and
parechovirus). In addition, blood (plasma and serum), vesicular fluid,
and biopsy specimen materials are tested for EVs when clinical presenta-
tions are compatible with enterovirus infections, such as hepatitis, myo-
carditis, or HFMD. For the detection of enteroviruses, we used a previ-
ously published protocol (26).
Patient characteristics (i.e., date of birth and sex) and clinical data (i.e.,
underlying condition, clinical presentation, and coinfections) were re-
corded. Repeated samples from the same patient within a 3-week period
yielding the same genotype were excluded. Identical EV genotypes from
differentmaterials from the same patient were included in the overview of
isolates per genotype, but only one isolate per patient per disease episode
was included in calculations for overall prevalence of the different EV
genotypes.
Sequencing and phylogenetic analysis. For the determination of the
genotype, we sequenced the VP1 gene as published previously byNix et al.
(27). For molecular analysis, the partial VP1 regions of all 367 EVs were
compared with the homologous sequences of prototype strains available
in GenBank as previously described (2).
In order to gainmore information on the uncommonEV-C genotypes
that were detected during this study, partial sequencing of the 5= untrans-
lated region (5= UTR) was performed on these strains using primers
DK001 (28) and EV-AII (TTCTGIGTIGAIACYTGWGCICCCAT), am-
plifying a 430- to 570-bp amplicon (nucleotide position 182 to 712, rela-
tive to the Tomkins coxsackievirus [CV] A1 strain). We also performed
partial sequencing of the 5= UTR of the four coxsackievirus A21 strains.
Sequencing was performed with an automated DNA sequencer (ABI
3130XL; Applied Biosystems Instrument, Carlsbad, CA, USA) using the
BigDye Terminator v3.1 cycle sequencing kit. Sequence data were ana-
lyzed using BioNumerics software 6.6 (Applied Maths, Sint-Martens-La-
tem, Belgium). The 5=-UTR sequences were aligned with enteroviruses A
to D as well as with rhinovirus A to C sequences, which were available in
GenBank. Subsequently, phylogenetic analysis was performed with the
EV-C strains detected in the respiratory samples included in our study
using the neighbor-joining algorithm with the nucleotide/Kimura two-
parameter method using BioNumerics software. The reliability of the
phylogenetic branching patterns was determined by the bootstrap resam-
pling test with 1,000 pseudoreplicates, which are shown as percentages.
Sequence similarity was also examined by the unweighted pair group
method using average linkages (UPGMA) using BioNumerics software.
Statistical analysis. Statistical analysis was done using chi-square
tests.
Accession number(s). The partial VP1 sequences and 5=-UTR se-
quences that were determined in this study have been deposited in the
GenBank sequence database under accession numbers KT735342 to
KT735354 and KT735355 to KT735367.
RESULTS
Screening 26,390 samples identified EV RNA in 399 samples from
351 individuals. EVs were detected in a variety of samples, includ-
ing in 105 respiratory samples of 14,565 (0.7%), in 5 out of 54 skin
lesions (9.3%), in 67 of 2,106 CSF samples (3.2%), in 214 of 9,510
fecal samples (2.2%), and in 8 of 155 blood samples (5.2%). Sub-
sequently, 365 isolates could be genotyped (92%) from328disease
episodes. A disease episode was defined as a single clinical period
during which virus, as well as clinical symptoms, was present.
Results of genotyping. Thirty-four detected EVs could not be
genotyped. The remaining 365 EV detections were from 65 CSF
samples, 5 vesicular fluids, 8 plasma samples, 97 respiratory sam-
ples, and 190 fecal samples (Fig. 1).
The EV genotype that was most frequently detected during the
study period was EV-D68. The 2 years with EV-D68 upsurges
(2010 and 2014) were the years with themost detected EVs overall
(Table 1). Even without the number of detected EV-D68, signifi-
cantlymore EVswere detected in 2014 than in the other years (n
61 versus an average of 45; P 0.02).
EV genotypes in vesicular fluid. The only genotypes found in
vesicular fluids were coxsackievirus CV-A6 and EV-A71. All five
patients were children with HFMD.
EVgenotypes in blood samples. Seven of eight EVs detected in
plasma were also detected in another clinical material, i.e., the
sameEV typewas detected inCSF once, in feces three times, and in
respiratory materials four times.
The eight patients with positive plasma samples presented
with neonatal sepsis three times (echovirus 9 [E-9] twice and
CV-B1 once), neonatal hepatitis once (E-19), neonatal myo-
carditis twice (CV-B1 and CV-B3), HFMD once (CV-A6), and
one pregnant woman presented with gastrointestinal symp-
toms and fever (CV-A9).
EV genotypes in CSF. CV-A9 and E-6 were each detected in
CSF eight times during this study. CV-A9howeverwasmore prev-
alent in materials other than CSF during the study period, with 21
positive tests from 16 disease episodes, compared to E-6, which
was detected 15 times from 12 disease episodes (Fig. 2).
EV-A was only detected in 5 out of 65 CSF samples (7.7%). All
but one patient were neonates with sepsis and symptoms of men-
ingitis. The one older infant presented with symptoms of viral
meningitis. Neurological infections in older children (1 year)
and adults were caused by EV-B (P 0.002). Viralmeningitis with
detectable EV in CSF was seen in 25 adults (15 years old) and 40
children. The median age of the adults was 35 (range, 21 to 62).
EV genotypes in feces. The most detected genotypes in feces
were CV-A6 (n  17), CV-B3 (n  15), CV-A16 (n  14), and
E-25 (n  14) (Fig. 1). Although enterovirus may have contrib-
uted to gastrointestinal symptoms in these mostly immunocom-
promised patients, there were no clearly identifiable cases of en-
terovirus gastrointestinal disease.
EVs from fecal samples were also detected in at least one other
clinicalmaterial in 21 cases; EVs detected in fecal samplesmade up
at least half of the total number of isolates for most genotypes,
excluding echovirus E-5, E-6, E-9, E-18, E-20, and E-30, of which
the majority of positive tests were in CSF. In addition, CV-B4,
CV-A21, EV-C109, and EV-D68 were predominantly detected in
respiratory samples.
Detection of poliovirus genotypes. Four poliovirus isolates
were genotyped as poliovirus 2 and poliovirus 3 andwere identical
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to the vaccine strains. These were found in fecal samples of young
children who had received an oral polio vaccination. All four chil-
dren were referred to our hospital with chronic bowel problems.
None were immunocompromised.
EV genotypes in respiratory materials. EVs belonging to all
four species A to D were detected in respiratory materials. Seven
percent (n 7) of EVs in respiratorymaterials belonged to species
A, 23% (n 22) belonged to species B, 13% (n 12) belonged to
species C, and 57% (n  55) belonged to species D. The most
prevalent EV type in respiratorymaterials during our study period
was EV-D68 (n 57 isolates from 55 disease episodes). Two pe-
riods were observed during which many patients presented with
respiratory disease caused by EV-D68. These upsurges in 2010 and
2014 were described separately (22, 29). Of note, in spite of EV-
D68 being the EV with the highest circulation in our study popu-
lation during the observed period, this virus was detected in only 3
fecal samples. All three patients had symptoms of respiratory ill-
ness beside gastrointestinal symptoms, which prompted the test-
ing of a fecal sample.
The second most frequently detected EV type in respiratory
materials was CV-B4 (7 times) (7%). All patients with this virus
were small children between the ages of 2 weeks and 4 years
(Fig. 3).
Species C EVs (excluding the four polio vaccine strains) were
predominantly detected in respiratory samples. Although the
overall prevalence of viruses belonging to this species was very low
during this study, i.e., 19 positive tests, 12 (63%) of these were in
respiratory samples. Also, while respiratory infections associated
with EV-A, EV-B, and EV-D species viruses mainly affected chil-
dren (5 years old), respiratory infections associated with EV-C
species viruses mainly affected adults (P 0.002).
Clinical characteristics of patients with C-group enterovi-
ruses. In view of the previously reported near absence of species C
EVs in the Netherlands (30), finding 19 non-polio EV-C geno-
types was notable. Moreover, during the study period, a total of 9
EVs were detected that are still considered to be rare. EV-C104,
EV-C105, and EV-C117 were each detected once, and EV-C109
was detected 7 times from 6 patients. The patients with EV-C105
and EV-C117 were previously healthy individuals, and the patient
with EV-C104 had a hematological malignancy. The six patients
with EV-C109, four adults and two children, all presented during
the winter of 2014 to 2015. Four out of six had coinfections, and
five out of six had underlying diseases (Table 2). One patient had
clinical signs and symptoms of viral meningitis with headache,
nausea, and vomiting. A CSF investigation showed an elevated
leukocyte count (32 106/liter), and enterovirus was detected in
CSF, although the amount of enterovirus RNA in the CSF was
insufficient for sequencing. EV-C109 was subsequently detected
in a respiratory specimen of this patient.
Three adult patients had respiratory infections with CV-A21.
All three had underlying medical conditions, and all three pre-
sented in the same period in 2013 (Table 2). CV-A21 was detected
in a fecal sample from one additional patient, a liver transplanta-
tion patient who had a coinfection with adenovirus. CV-A1, CV-
A11, CV-A20, and CV-A22 were only detected in feces and were
presumably incidental findings. In our multiplex screening assay,
FIG 1 Enterovirus genotypes detected in this study per clinical material from which they were isolated. E, echovirus; EV, enterovirus; CV, coxsackievirus; CSF,
cerebrospinal fluid.
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only the EV-C117was detected by the rhinovirus test as well as the
EV test.
Phylogenetic analysis of species C enteroviruses. The VP1
sequences of the six EV-C109 detections were obtained to de-
termine the homology with the EV-C109 strains available in
GenBank by the neighbor-joining method using BioNumerics
software. The VP1 dendrogram (Fig. 4A) shows that the six EV-
C109 detections from this study are clustered together (strains
identified by GRO prefix in all phylogenetic trees) with a nucleo-
tide divergence of less than 8%, with the nearest previously de-
scribed strain from Hungary (23). Among the local strains from
this study, the nucleotide divergence is less than 2.5%.
By comparison, the VP1 sequences of the four local CV-A21
detections (also identified by the GRO prefix) were obtained to
determine the homology among these strains and strains available
in GenBank. Nucleotide divergence within the local CV-A21 clus-
ter is 0.5% to 5%,whereas nucleotide divergence between the local
CV-A21 strains and the closest previously published strains is less
than 7%. The dendrogram (Fig. 4B) shows that the CV-A21
strains are most closely related to strains isolated in 2006 in the
United States (3).
The VP1 sequences of the single detections of EV-C104, EV-
C105, and EV-C117 were obtained, and all of these were used for
the construction of the VP1 unrooted phylogenetic tree in Fig. 5A.
The VP1 neighbor-joining tree shows the grouping of all species C
viruses from the present study, clustering with their prototypic
counterparts, within the clade of EV-C.
Because significant divergence has been shown in the 5= UTR
of the new EV-C viruses, EV-C104, EV-C105, EV-C109, and EV-
C117, compared to the “classical” EV-C viruses, we also se-
TABLE 1 Number of detected enterovirus genotypes per year, in the Northern part of the Netherlands between January 2008 and April 2015
Genotype
Year
Total no.2008 2009 2010 2011 2012 2013 2014 2015
CV-A2 1 4 4 9
CV-A4 2 2 3 1 4 12
CV-A5 1 1 2 3 7
CV-A6 5 1 3 5 12 26
CV-A8 0 1 1 2
CV-A10 3 2 1 6
CV-A16 5 4 1 4 1 2 17
EV-71 0 1 4 2 7
CV-A9 0 17 2 2 21
CV-B1 1 1 2
CV-B2 1 2 4 1 8
CV-B3 8 1 3 8 3 23
CV-B4 6 1 2 3 1 13
CV-B5 1 6 2 1 2 12
E-3 1 1
E-5 1 5 6
E-6 9 1 1 4 15
E-7 5 6 11
E-9 2 2 5 1 1 2 13




E-18 1 1 4 6 2 14
E-19 3 3
E-20 1 1
E-25 8 6 4 18
E-30 7 1 2 10







EV-C109 2 5 7
EV-C117 1 0 1
PV-2 1 1 2
PV-3 1 1 2
EV-D68 4 25 3 1 23 1 57
Total no. 44 33 72 43 42 36 84 11 365
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quenced this region in all of the EVs included in this study. The
unrooted neighbor-joining tree shows that these new EV-C vi-
ruses form a separate clade, while the four CV-A21 isolates cluster
with the other “classical” EVs of species C (Fig. 5B).
DISCUSSION
With this report, we present the data from the routine genotyping
of all EVs detected in our tertiary care hospital between January
2008 and April 2015. Forty different EV genotypes were detected
in our clinical virology laboratory. During the study period, EV
diversity was dominated by two upsurges of EV-D68 in respira-
tory samples, one in 2010 and one in 2014, which together with
nine sporadic cases in the remaining study years account for 16%
of the typeable isolates. Interestingly, only three fecal samples dur-
ing the study period had detectable EV-D68. All three patients also
had respiratory illness, most likely caused by this virus. While in
this study most EVs detected in fecal samples represented back-
ground circulation, it is interesting that this virus was not detected
as an incidental finding in patients presenting with other symp-
toms. Previous studies that have investiged EV-D68 report that
the detection of EV-D68 appears to be restricted to respiratory
materials (30). However, no EV genotype prevalence studies exist
that include years with EV-D68 outbreaks. Considering the very
low overall prevalence of EVs in respiratorymaterials (0.7%), EVs
did not appear to be important respiratory pathogens outside of
the two EV-D68 outbreak years. Moreover, all EVs probably rep-
licate to some extent in the nasopharyngeal epitheliumandmaybe
FIG 2 Age distribution of the enterovirus genotypes detected in cerebrospinal fluid. E, echovirus; EV, enterovirus; CV, coxsackievirus.
FIG 3 Age distribution of the enterovirus genotypes detected in respiratory materials. E, echovirus; EV, enterovirus; CV, coxsackievirus.
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detectable in respiratory samples (1). Nevertheless, the genotypes
thatwe detected in respiratorymaterialswere significant.While 41
respiratorymaterials were positive for EVs other than EV-D68, 12
(29%) of these were EV-C genotypes. Twenty-three species C EVs
were detected, which is remarkable because similar studies to ours
in the past have found very few, if any, EVs belonging to the EV-C
group (31, 32). Many of these studies, however, did not include
respiratory materials, which is where most species C EVs were
found in this study. The classical CV-A21 was detected in respira-
tory secretions of three patients who all presented with severe
TABLE 2 Clinical characteristics of the patients who presented with infections associated with EV-C
EV type Sexa Age Date Material Clinical presentation Coinfections Underlying condition
EV-C109 M 7 yr 13 December 2014 Respiratory Mild respiratory illness and vesicles CV-A6 Renal transplantation
EV-C109 F 35 yr 26 December 2014 Respiratory Fever, cough Influenza A Cyclical neutropenia
EV-C109 F 6 mo 28 January 2014 Respiratory Fever/respiratory distress HMPV None
EV-C109 M 32 yr 1 February 2015 Respiratory Viral meningitisb None Lymphoma
EV-C109 F 59 yr 3 February 2015 Respiratory/feces Nausea, vomiting Norovirus Lung transplantation
EV-C109 F 62 yr 17 February 2015 Respiratory Mild respiratory illness None Lung transplantation
CV-A21 F 17 yr 8 August 2013 Feces Diarrhea Adenovirus Liver transplantation
CV-A21 M 59 yr 19 September 2013 Respiratory Cold reduced lung function None Lung transplantation
CV-A21 F 38 yr 5 November 2013 Respiratory Asthma exacerbation None Asthma
CV-A21 M 52 yr 10 December 2013 Respiratory SOBc, pleuritic pain, pericarditis None Lymphoma
EV-C117 M 27 yr 23 December 2013 Respiratory Mild cold None None
EV-C104 F 10 yr 2 January 2014 Respiratory Seizure None Leukemia
EV-C105 M 19 yr 3 September 2014 Respiratory Pneumonia Streptococcus pneumoniae None
a F, female; M, male.
b This patient, undergoing treatment for malignant lymphoma, presented with symptoms of viral meningitis and elevated lymphocyte count in cerebrospinal fluid. Enterovirus was
detected in cerebrospinal fluid but with an insufficient load for genotyping. EV-C109 was detected in a sample of respiratory material.
c SOB, shortness of breath.
FIG 4 Neighbor-joining phylogeny showing the relationships among the 6 EV-C109 strains from this study (A) as well as the 6 strains that are available in
GenBank, based on the alignment of and partial VP1 (322 to 325 nucleotides [nt]) sequences. (B) The neighbor-joining phylogenetic relationships among the 4
CV-A21 strains from this study and reference strains fromGenBank. Trees were constructed using BioNumerics software. Bootstrap values (percentage of 1,000
pseudoreplicate data sets) are shown at the nodes. Bars represent the genetic distance. A strain name indicates a GenBank accession number/country or area/year
of isolation. GRO, these sequences have been identified as part of this present study. Bar, nucleotide distance as substitutions per site.
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respiratory illness in the fall of 2013. One instance of CV-A21 was
detected in the feces of a patient with diarrhea, probably an inci-
dental finding. CV-A21 is currently a well-recognized cause of
respiratory problems (33). The sequence analyses of the CV-A21
isolates in this study show that they are closely related and that
they are very similar to CV-A21 circulating in North America (3).
Additionally, the presence of the new EV-C genotypes EV-104,
EV-105, EV-109, and EV-117 is of importance. To date, very few
viruses of these genotypes have been reported worldwide. Of EV-
C104, EV-C105, EV-C109, and EV-C117, the total number of iso-
lates described worldwide is less than 10 each (19–25). Especially
for EV-C109, which appears to be extremely rare, it is remarkable
that six patients with this virus were found in a relatively small
study. It is possible that EV-C109 was only recently introduced in
Europe or thatwe experienced a small upsurge of an otherwise low
pathogenic virus, which was only found because of the vulnerable
patient population in our hospital. Yet, two other reasons have to
be considered.
This study shows that the 5=UTR, which is frequently used as a
target for molecular tests, is significantly different for these vi-
ruses, confirmingwhat has been reported by other researchers (12,
16, 17). The divergence in the 5=UTR is likely to lead to difficulties
in detecting these viruses. Undeniably, this has already been an
issue in one of the AFP cases (20). Another reason may be the
exclusion of respiratory materials in many epidemiological stud-
ies such as ours (31, 32).
Because of the particular patient population in our hospital
and the relatively small sample size, it is not possible to draw any
conclusions about the importance of respiratory EVs other than
EV-D68 at this time. The exceptional patient population of this
study is exemplified by the low number of vesicular fluids in-
cluded in this report, as HFMD is typically a diagnosis made in
general practice and also by the clinical characteristics of the pa-
tients presentingwith respiratory infections associatedwith EV-C.
The data generated in this study are therefore not suitable for
determining the prevalence of viruses.
A representative picture of genotype prevalence and associated
disease can only be obtained if different health care providers col-
laborate in collecting samples and data. Therefore, we have started
a regional surveillance network that is aimed at genotypic analysis
of all EVs detected in the northern part of theNetherlands. Ideally,
this regional network would be linked to other regional networks,
spanning a country of even multiple countries (34). Recently, a
network such as this that is aimed at rapid detection and genotyp-
ing of EV-D68 was formed throughout Europe, showing the pre-
paredness and the motivation of many laboratories and health
institutions to participate in a Europe-wide network (11). Good
detection assays for EVs are an obvious prerequisite for a func-
tioning network.
In conclusion, this study shows the circulating EV genotypes in
a tertiary care hospital in the Netherlands. The detection of a large
number of EVs in respiratory materials in patients with respira-
tory illnesses confirms that some EVs are considerable respiratory
pathogens.Moreover, although they are not associated with ama-
jor impact on public health, our study shows that newly described
EVs were found to circulate in the Netherlands when respiratory
samples were tested.
FIG 5 Phylogenetic relationships based on partial VP1 sequences (A) and 5=-UTR sequences (B) of the EV-C isolates from this study, identified by GRO (yellow
dots), compared with prototype strains of EV-A, EV-B, EV-C, EV-D, and rhinovirus (RV)-A, RV-B, and RV-C (green dots). Relationships were constructed
using the neighbor-joining algorithm. Genotype and country of isolation of each reference strain are indicated. Bootstrap values (percentage of 1,000 pseu-
doreplicate data sets) are shown at the nodes. Bar, nucleotide distance as substitutions per site.
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